Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene. 1998

N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
Division of Biology and Oncology, National Institute of Radiological Sciences, Chiba, Japan.

The complement system plays an important role in defense mechanisms by promoting the adherence of microorganisms to phagocytic cells and lysis of foreign organisms. Deficiencies of the first complement components, C1r/C1s, often cause systemic lupus erythematosus-like syndromes and severe pyogenic infections. Up to now no genetic analysis of the C1r/C1s deficiencies has been carried out. In the present work, we report the first genetic analysis of selective C1s deficiency, the patient having a normal amount of C1r. C1s RNA with a normal size was detected in patient's subcutaneous fibroblasts (YKF) by RNA blot analysis and RT-PCR. The amount of C1s RNA was approximately one-tenth of the RNA from the human chondrosarcoma cell line, HCS2/8. In contrast, the levels of C1r and beta-actin RNA of YKF were similar to that of HCS2/8. Sequence analysis of C1s cDNA revealed a deletion at nucleotides 1087-1090 (TTTG), creating a stop codon (TGA) at position 94 downstream of the mutation site. Direct sequencing of the gene between the primers designed on intron 9 and exon 10 indicated the presence of the deletion on exon 10 of the gene. Quantitative Southern blot hybridization suggested the mutation was homozygous. The 4-bp deletion on exon 10 was also found in the patient's heterozygous mother who had normal hemolytic activity.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D003173 Complement C1s A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme (homodimer) in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A (heavy) and B (light, the serine protease), linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a (CLASSICAL C3 CONVERTASE). C 1 Esterase,C1 Esterase,C1s Complement,Complement 1 Esterase,Complement 1s,Complement Component 1s,C1s, Complement,Complement, C1s,Component 1s, Complement,Esterase, C 1,Esterase, C1,Esterase, Complement 1
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D017384 Sequence Deletion Deletion of sequences of nucleic acids from the genetic material of an individual. Deletion Mutation,Deletion Mutations,Deletion, Sequence,Deletions, Sequence,Mutation, Deletion,Mutations, Deletion,Sequence Deletions
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA

Related Publications

N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
March 1998, Human molecular genetics,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
January 2018, JIMD reports,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
November 2005, American journal of medical genetics. Part A,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
February 1999, Journal of immunology (Baltimore, Md. : 1950),
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
June 2018, European journal of human genetics : EJHG,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
March 2008, Molecular immunology,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
February 2023, Journal of clinical research in pediatric endocrinology,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
May 2015, European journal of pediatrics,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
November 2013, Haemophilia : the official journal of the World Federation of Hemophilia,
N Inoue, and T Saito, and R Masuda, and Y Suzuki, and M Ohtomi, and H Sakiyama
April 2008, Molecular genetics and metabolism,
Copied contents to your clipboard!